Syngene International Ltd

BSE :539268 NSE :SYNGENE Sector : Healthc..
718.15
Change: -1.40(-0.19%)
52 week Low
607.65
52 week High
960.60
Day low
714.50
Day high
728.35
Prev Close
719.55
Open
723.20
6M return
-20.06%
1Y return
2.22%
MCap(Rs. in Cr.)
29,232.24
Total Volume
2,80,977
Face Value : 10
Listed Since 11 Aug 2015
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
61.22260
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
11.86
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
6.58
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
53.03%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.17

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
726.60
Resistance 2
733.65
Support 1
711.25
Support 2
702.95

Moving Average

20 Days
689.51
50 Days
725.47
100 Days
801.11
200 Days
809.74
Growth in 3 years

Sales
33.96%

Sales Industry Avg
24.91%

PAT
28.85%

PAT Industry Avg
2.79%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales943.70891789.70916.903,488.60
Gross Profit289.50248.20208.20320.101,046.70
Operating Profit00000
Profit Before Tax176133.5094.90231620.80
Tax44.9027.4019.2042.40110.80
Profit After Tax131.10106.1075.70188.60510
Growth in 3 years

Total Asset Growth
10.46%

Total Liabilities growth
10.46%

Reserves Change
33.11%

Mar 2024
( in Cr.)
Mar 2023
( in Cr.)
Mar 2022
( in Cr.)
Mar 2021
( in Cr.)
Mar 2019
( in Cr.)
Share Capital402401.40400.80400200
Reserves And Surplus3,855.803,216.602,896.802,421.401,768.40
Investments547.90918.501,034.10702716
Total Debt839.701,136.801,317.201,204.101,058.10
Total Liabilities5,097.504,754.804,614.804,025.503,026.50
Total Assets5,097.504,754.804,614.804,025.503,026.50
7.50%
2023
12.50%
2024 2025
2026


Relative to Sensex rtn in 3 year
-32.87%

Relative to Nifty rtn in 3 year
-37.75%



1 Year (%)2 Year (%)3 Year (%)
Syngene Intl.22421
Bse Sensex33232
Nifty 5043735
Nifty 50044844

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Syngene Intl.
718.15
Change: -1.40 (-0.19%)
1 Year return
2.22%
Risk (Std Dev)
0.09%
PE Ratio
61.22260
MCap( in Cr.)
29,232.24
Max Healthcare
1,083.60
Change: -45.80 (-4.06%)
1 Year return
32.16%
Risk (Std Dev)
0.10%
PE Ratio
100.52246
MCap( in Cr.)
1,06,639.12
Apollo Hospitals
6,632.30
Change: 140.25 (2.16%)
1 Year return
4.33%
Risk (Std Dev)
0.07%
PE Ratio
72.67669
MCap( in Cr.)
95,130.80
Fortis Health.
688.65
Change: 16.85 (2.51%)
1 Year return
63.89%
Risk (Std Dev)
0.07%
PE Ratio
66.84211
MCap( in Cr.)
52,722.50
Narayana Hrudaya
1,676.80
Change: 3.40 (0.20%)
1 Year return
30.61%
Risk (Std Dev)
0.06%
PE Ratio
44.10300
MCap( in Cr.)
34,578.87
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,02,220.50 with a Gain of 2.22%

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

Results Update 06 Nov 2020 3:14 AM
As compared to the previous quarter, Revenue in Q2FY21 has witnessed a growth of 23.24% and amounts to Rs. 519.6 Cr. The Revenue also gone up by 11.84% over Q2FY20. Sales continued to increase from Q..
Results Update 27 Jul 2020 4:59 PM
As compared to the previous quarter, Revenue in Q1FY21 has witnessed a growth of 30.58% and amounts to Rs. 421.6 Cr.
Results Update 15 May 2020 4:38 PM
Revenue increased by 16.99% to Rs. 607.3 Cr in Q4FY20 when compared to the previous quarter.

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

D D
2023
D
2024
2025

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

Syngene International Ltd 719.55 Chg: -7.90(-1.09%) Expiry Month 24 Apr 2025
Day's Low
716.60
Day's High
731.85
Day’s Open
716.60
Prev Close
727.45
Volume
6,46,000
OI
60,44,000
OI Change (%)
-0.30
View More

News

Stay tuned to the latest developments and happenings in the company.

Syngene acquires its first biologics site in Baltimore, USA

Syngene International (Syngene) today announced the acquisition of its first biologics site in the USA - fitted with multiple monoclonal antibody (....

10 Mar 2025 19:13

Syngene International consolidated net profit rises 17.58% in the December 2024 quarter

Net profit of Syngene International rose 17.58% to Rs 131.10 crore in the quarter ended December 2024 as against Rs 111.50 crore during the previous q....

23 Jan 2025 16:31

Syngene International to announce Quarterly Result

Syngene International will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live Ne....

13 Jan 2025 17:29

Syngene International consolidated net profit declines 8.93% in the September 2024 quarter

Net profit of Syngene International declined 8.93% to Rs 106.10 crore in the quarter ended September 2024 as against Rs 116.50 crore during the previo....

23 Oct 2024 17:47

Board of Syngene International approves change in management

The Board of Syngene International at its meeting held on 23 October 2024 has approved the following change in management:Resignation of Sibaji Bis....

23 Oct 2024 15:34

Syngene International consolidated net profit declines 18.95% in the June 2024 quarter

Net profit of Syngene International declined 18.95% to Rs 75.70 crore in the quarter ended June 2024 as against Rs 93.40 crore during the previous qua....

24 Jul 2024 16:19

View More
Subscribe for our
newsletter
Open Account Now